Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
April 27, 2018Paul G. Richardson, MD: One size fits all for induction therapy in myeloma: What you need to knowWebcast: Great Debates and Updates in Hematologic Malignancies 201818 minPlay
April 27, 2018Edward A. Stadtmauer, MD: Current and emerging novel immunotherapies for myelomaWebcast: Great Debates and Updates in Hematologic Malignancies 201822 minPlay
April 27, 2018Ruben Niesvizky, MD: Four drug regimens should be standard for myeloma salvage therapyWebcast: Great Debates and Updates in Hematologic Malignancies 201819 minPlay
April 27, 2018Marlise R. Luskin, MD: CML and pregnancy: Patient and partner considerationsWebcast: Great Debates and Updates in Hematologic Malignancies 201821 minPlay
April 27, 2018Richard R. Furman, MD: Debate: Will novel-agent based combination therapy become standard of care for CLL? - NoWebcast: Great Debates and Updates in Hematologic Malignancies 201816 minPlay
April 27, 2018Jose F. Leis, MD: What to do after BTKi therapy failsWebcast: Great Debates and Updates in Hematologic Malignancies 201826 minPlay
April 27, 2018Richard R. Furman, MD: Monoclonal B cell lymphocytosis: Are there patients who need close follow-up?Webcast: Great Debates and Updates in Hematologic Malignancies 201822 minPlay
April 27, 2018Amer Zeidan, MD: Newly approved drugs for AMLWebcast: Great Debates and Updates in Hematologic Malignancies 201822 minPlay
April 27, 2018Amer Zeidan, MD: Debate: Clinical scenarios in AML: Traditional vs targeted therapy - TraditionalWebcast: Great Debates and Updates in Hematologic Malignancies 201815 minPlay
April 27, 2018Gunther Koehne, MD: Debate: Clinical scenarios in AML: Traditional vs targeted therapy - TargetedWebcast: Great Debates and Updates in Hematologic Malignancies 201813 minPlay